Galactosidase alpha (GLA) (NM_000169) Human Recombinant Protein
CAT#: TP720304L
Recombinant protein of human galactosidase, alpha (GLA)
Need it in bulk or customized? Get a free quote |
CNY 18,030.00
货期*
2周
规格
经常一起买 (2)
Specifications
Product Data | |
Species | Human |
Expression Host | HEK293 |
Expression cDNA Clone or AA Sequence |
Leu32-Leu429
|
Tag | C-His |
Predicted MW | 46.4 kDa |
Concentration | lot specific |
Purity | >95% as determined by SDS-PAGE and Coomassie blue staining |
Buffer | Provided lyophilized from a 0.2 μm filtered solution of 20 mM Tris-HCl, 150 mM NaCl |
Storage | Store at -80°C. |
Stability | Stable for at least 3 months from date of receipt under proper storage and handling conditions. |
Endotoxin | < 0.1 EU per µg protein as determined by LAL test |
Reference Data | |
RefSeq | NP_000160 |
Locus ID | 2717 |
UniProt ID | P06280, Q53Y83 |
Cytogenetics | Xq22.1 |
Synonyms | GALA |
Summary | This gene encodes a homodimeric glycoprotein that hydrolyses the terminal alpha-galactosyl moieties from glycolipids and glycoproteins. This enzyme predominantly hydrolyzes ceramide trihexoside, and it can catalyze the hydrolysis of melibiose into galactose and glucose. A variety of mutations in this gene affect the synthesis, processing, and stability of this enzyme, which causes Fabry disease, a rare lysosomal storage disorder that results from a failure to catabolize alpha-D-galactosyl glycolipid moieties. [provided by RefSeq, Jul 2008] |
Protein Families | Druggable Genome |
Protein Pathways | Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo series, Lysosome, Sphingolipid metabolism |
Documents
FAQs |
SDS |
其它Galactosidase alpha产品
Customer
Reviews
Loading...